A recipient risk score for deceased donor renal allocation.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMID 17261431)

Published in Am J Kidney Dis on February 01, 2007

Authors

Edwina S Baskin-Bey1, Walter Kremers, Scott L Nyberg

Author Affiliations

1: Division of Transplantation Surgery, William J. von Liebig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA.

Articles by these authors

Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11

Acute liver failure: Summary of a workshop. Hepatology (2008) 3.49

Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology (2006) 2.62

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation (2002) 1.86

Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis (2001) 1.81

Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79

Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl (2007) 1.64

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant (2011) 1.51

Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation (2006) 1.43

Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology (2009) 1.41

Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis (2004) 1.34

MELD and other factors associated with survival after liver transplantation. Am J Transplant (2004) 1.34

Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant (2003) 1.29

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation (2004) 1.29

Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol (2012) 1.29

Cell therapies for liver diseases. Liver Transpl (2012) 1.24

Artificial and bioartificial liver support. Semin Liver Dis (2008) 1.21

Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol (2004) 1.17

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis (2002) 1.13

Portal hypertension correlates with splenic stiffness as measured with MR elastography. J Magn Reson Imaging (2011) 1.10

Transplantation for hilar cholangiocarcinoma. Liver Transpl (2004) 1.05

ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation (2003) 1.04

E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism. Cell Transplant (2009) 1.04

Gene expression during acute allograft rejection: novel statistical analysis of microarray data. Am J Transplant (2002) 1.01

Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant (2004) 1.01

Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies. Stem Cell Res (2012) 1.00

Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg (2012) 0.99

Living donor liver transplantation using a right lobe graft in an adult with situs inversus. Liver Transpl (2005) 0.97

Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer. Hepatology (2011) 0.97

Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation (2002) 0.94

Improving the prediction of donor kidney quality: deceased donor score and resistive indices. Transplantation (2005) 0.93

In utero transplanted human hepatocytes allow postnatal engraftment of human hepatocytes in pigs. Liver Transpl (2013) 0.91

Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant (2003) 0.90

Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure. J Surg Res (2012) 0.89

Effect of neurologic complications on outcome after heart transplant. Arch Neurol (2008) 0.89

Serum-free medium and mesenchymal stromal cells enhance functionality and stabilize integrity of rat hepatocyte spheroids. Cell Transplant (2012) 0.89

Membrane pore size impacts performance of a xenogeneic bioartificial liver. Transplantation (2003) 0.88

Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors. HPB (Oxford) (2014) 0.88

Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys. J Am Coll Surg (2013) 0.87

Normal atmospheric oxygen tension and the use of antioxidants improve hepatocyte spheroid viability and function. J Cell Physiol (2011) 0.87

United Network for Organ Sharing's expanded criteria donors: is stratification useful? Clin Transplant (2005) 0.86

Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients. Am J Kidney Dis (2012) 0.85

Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys? Transplant Rev (Orlando) (2008) 0.85

Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int (2004) 0.84

Decline in native renal function early after bladder-drained pancreas transplantation alone. Transplantation (2004) 0.83

Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver. Biotechnol Bioeng (2009) 0.83

Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int (2013) 0.82

Apoptotic cell death and function of cryopreserved porcine hepatocytes in a bioartificial liver. Cell Transplant (2003) 0.81

Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation. Transplantation (2004) 0.80

LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay. Transplantation (2013) 0.79

Engineering analysis and development of the spheroid reservoir bioartificial liver. Conf Proc IEEE Eng Med Biol Soc (2009) 0.79

Keratin, fas, and cryptogenic liver failure. Liver Transpl (2002) 0.78

Routine use of livers from deceased donors older than 70: is it justified? Transpl Int (2005) 0.78

Gene expression and functional analyses of primary rat hepatocytes on nanofiber matrices. Cells Tissues Organs (2009) 0.78

Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene. Liver Transpl (2015) 0.78

Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation (2007) 0.78

Extracorporeal treatment of acute liver failure. Hepatol Res (2008) 0.78

Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery (2002) 0.78

Efficacy, Safety, and Tolerability of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies: A Pilot Study. Dement Geriatr Cogn Disord (2017) 0.78

Improving utilization of deceased donor kidneys by matching recipient and graft survival. Transplantation (2006) 0.77

Suspension culture of hepatocyte-derived reporter cells in presence of albumin to form stable three-dimensional spheroids. Biotechnol Bioeng (2013) 0.77

Cell therapy in chronic liver disease. Curr Opin Gastroenterol (2016) 0.75

What's the score? Clin Transplant (2004) 0.75

Cold storage of rat hepatocyte spheroids. Cell Transplant (2013) 0.75

Delayed Reconstruction for Symptomatic Anterior Cruciate Ligament Tears: A population-based study: 3102 Board #167 June 3, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc (2016) 0.75

Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts. Cells Tissues Organs (2017) 0.75

Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts. Cells Tissues Organs (2016) 0.75

Late presentation of pylephlebitis after orthotopic liver transplantation. Liver Transpl (2003) 0.75

Treatment of persistent/medically refractory covert hepatic encephalopathy with the molecular adsorbent recirculating system. Liver Transpl (2014) 0.75

EXTRACORPOREAL APPLICATION OF A GEL-ENTRAPMENT, BIOARTIFICIAL LIVER: DEMONSTRATION OF DRUG METABOLISM AND OTHER BIOCHEMICAL FUNCTIONS. Cell Transplant (1993) 0.75

Preliminary report of the Hepatic Encephalopathy Assessment Driving Simulator (HEADS) score. Ethn Dis (2008) 0.75